TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 65 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $442,463 | +482.5% | 140,020 | +21.8% | 0.00% | – |
| Q2 2023 | $75,962 | -17.1% | 114,920 | 0.0% | 0.00% | – |
| Q1 2023 | $91,660 | -82.4% | 114,920 | -50.0% | 0.00% | – |
| Q4 2022 | $519,438 | +248.6% | 229,840 | +196.9% | 0.00% | – |
| Q3 2022 | $149,000 | -48.3% | 77,420 | 0.0% | 0.00% | – |
| Q2 2022 | $288,000 | -91.2% | 77,420 | -84.5% | 0.00% | – |
| Q1 2022 | $3,255,000 | -39.8% | 499,214 | +7.6% | 0.00% | – |
| Q4 2021 | $5,408,000 | -17.5% | 464,169 | +31.8% | 0.00% | – |
| Q3 2021 | $6,558,000 | -2.9% | 352,186 | +10.5% | 0.00% | – |
| Q2 2021 | $6,755,000 | +172.5% | 318,619 | +160.9% | 0.00% | – |
| Q1 2021 | $2,479,000 | -15.2% | 122,141 | +10.9% | 0.00% | – |
| Q4 2020 | $2,922,000 | – | 110,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 1,147,040 | $13,363,000 | 6.07% |
| Sands Capital Ventures, LLC | 724,873 | $8,445,000 | 1.25% |
| Quantum Private Wealth, LLC | 145,718 | $1,697,000 | 0.64% |
| Nantahala Capital Management | 1,456,147 | $16,964,000 | 0.60% |
| Artal Group S.A. | 1,040,882 | $12,126,000 | 0.33% |
| Alphabet Inc. | 640,882 | $7,466,000 | 0.18% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $5,825,000 | 0.17% |
| TimesSquare Capital Management, LLC | 659,100 | $7,679,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 40,885 | $476,000 | 0.06% |
| Virtus ETF Advisers LLC | 11,519 | $134,000 | 0.05% |